258 related articles for article (PubMed ID: 23197161)
1. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H
Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Axelsson A; Køber L; Bundgaard H
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1511-8. PubMed ID: 26231341
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic diagnosis of familial hypertrophic cardiomyopathy: Results in pediatric cardiology.
Cardoso B; Gomes I; Loureiro P; Trigo C; Ferreira Pinto F
Rev Port Cardiol; 2017 Mar; 36(3):155-165. PubMed ID: 28214152
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.
van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M
Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763
[TBL] [Abstract][Full Text] [Related]
5. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy in myosin-binding protein C (
Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
9. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin.
Protonotarios N; Tsatsopoulou A; Anastasakis A; Sevdalis E; McKoy G; Stratos K; Gatzoulis K; Tentolouris K; Spiliopoulou C; Panagiotakos D; McKenna W; Toutouzas P
J Am Coll Cardiol; 2001 Nov; 38(5):1477-84. PubMed ID: 11691526
[TBL] [Abstract][Full Text] [Related]
11. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.
Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP
Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259
[TBL] [Abstract][Full Text] [Related]
12. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
Maron BJ; Maron MS; Semsarian C
J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
[TBL] [Abstract][Full Text] [Related]
14. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
[TBL] [Abstract][Full Text] [Related]
15. Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive.
Vermeer AMC; Clur SB; Blom NA; Wilde AAM; Christiaans I
J Pediatr; 2017 Sep; 188():91-95. PubMed ID: 28396031
[TBL] [Abstract][Full Text] [Related]
16. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
[TBL] [Abstract][Full Text] [Related]
17. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.
Christiaans I; Birnie E; Bonsel GJ; Mannens MM; Michels M; Majoor-Krakauer D; Dooijes D; van Tintelen JP; van den Berg MP; Volders PG; Arens YH; van den Wijngaard A; Atsma DE; Helderman-van den Enden AT; Houweling AC; de Boer K; van der Smagt JJ; Hauer RN; Marcelis CL; Timmermans J; van Langen IM; Wilde AA
Eur Heart J; 2011 May; 32(9):1161-70. PubMed ID: 21459882
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
[TBL] [Abstract][Full Text] [Related]
20. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
Brito D; Richard P; Komajda M; Madeira H
Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
